Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Growth stocks coverage continues on proactiveinvestors.com Go there →

Company

Oxford BioMedica PLC

LON:OXB

Oxford BioMedica is a biopharmaceutical company specialising in the development and commercialisation of innovative gene-based medicines. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock Exchange. Oxford BioMedica's products use genes as the mediators of a therapeutic effect and/or immune response. The company has a platform of gene delivery technologies, which are predominately based on highly engineered viral systems. Oxford BioMedica has core expertise in gene delivery, as well as in-house clinical, regulatory and manufacturing know-how.

69 stories · page 4 of 4